Revenue and Profitability - Revenue for the three months ended January 28, 2023, was $134.4 million, compared to $90.1 million for the same period in 2022, representing a 49% increase[192]. - Revenue for the three months ended January 28, 2023, was $134.4 million, an increase of $44.3 million, or 49%, compared to $90.1 million for the same period in 2022[196]. - Gross margin for the three months ended January 28, 2023, was $45.5 million, up from $21.4 million in the prior year, indicating a significant improvement in profitability[192]. - Gross margin for the three months ended January 28, 2023, was $45.5 million, representing an increase of $24.1 million, or 112%, compared to $21.4 million for the same period in 2022[198]. - Gross margin for the nine months ended January 28, 2023, was $105.1 million, a 13% increase from $92.6 million in the previous year, maintaining a gross margin percentage of 30%[217]. Expenses - Research and development expenses for the three months ended January 28, 2023, were $16.2 million, compared to $13.0 million for the same period in 2022, reflecting a 24% increase[192]. - Selling, general, and administrative expenses for the three months ended January 28, 2023, were $24.7 million, slightly higher than $22.5 million in the prior year[192]. - Selling, General and Administrative (SG&A) expenses for the three months ended January 28, 2023, were $24.7 million, or 18% of revenue, compared to $22.5 million, or 25% of revenue, for the same period in 2022[201]. - Research and Development (R&D) expenses for the three months ended January 28, 2023, were $16.2 million, or 12% of revenue, compared to $13.0 million, or 14% of revenue, for the same period in 2022[202]. - SG&A expenses decreased to $70.3 million, or 20% of revenue, compared to $74.5 million, or 24% of revenue, for the same period in 2022[218]. - R&D expenses increased to $47.8 million, or 13% of revenue, from $41.0 million, also 13% of revenue, due to enhanced product capabilities and new product line development[218]. Net Loss and Adjusted Income - The company reported a net loss of $0.7 million for the three months ended January 28, 2023, compared to a net loss of $35,000 for the same period in 2022[192]. - Adjusted income from operations for the three months ended January 28, 2023, was $12.0 million, compared to an adjusted loss of $4.4 million for the same period in 2022[196]. Cash Flow and Backlog - Net cash provided by operating activities increased by $32.0 million to $8.8 million for the nine months ended January 28, 2023, compared to a net cash used of $23.2 million in the prior year[236]. - Funded backlog as of January 28, 2023, was approximately $413.9 million, up from $210.8 million as of April 30, 2022[224]. - Unfunded backlog was $387.0 million as of January 28, 2023, including a $235.2 million contract pending export license approval[225]. Interest Expense and Tax Rate - Interest expense, net for the three months ended January 28, 2023, was $2.8 million, compared to $1.5 million for the same period in 2022, primarily due to higher interest rates[202]. - Interest expense, net for the nine months ended January 28, 2023, was $6.7 million, an increase from $4.2 million in the same period in 2022, primarily due to higher interest rates[219]. - The effective income tax rate for the three months ended January 28, 2023, was 67.2%, down from 98.7% for the same period in 2022[204]. - Effective income tax rate decreased to 38.3% for the nine months ended January 28, 2023, from 69.1% in the prior year, influenced by expected federal R&D tax credits[220]. Risks and Future Outlook - The MUAS reporting unit is at an increased risk of failing future quantitative goodwill impairment tests, with its estimated fair value exceeding its carrying value by approximately 10%[188]. - The company expects lower levels of MUAS service revenues to continue into fiscal 2024 due to the completion of certain MUAS site locations[196]. - The company anticipates inflationary and supply chain constraints to continue impacting gross margin throughout fiscal year 2023[201]. Foreign Exchange and Financing Activities - The company has not experienced significant foreign exchange gains or losses, as a significant part of sales and expenses are in U.S. dollars[243]. - The acquisition of Telerob for $46.2 million impacted cash flows, with a portion of cash now denominated in Euros[237][243]. - The current outstanding balance of the Credit Facilities is $167.5 million, bearing a variable interest rate, which may increase if market interest rates continue to rise[241]. - The market interest rate has increased significantly, which could lead to higher interest payments on the Credit Facilities[241].

AeroVironment, Inc. (NASDAQ:AVAV) Q2 2023 Earnings Conference Call December 6, 2022 4:30 PM ET Company Participants Jonah Teeter-Balin - Senior Director-Corporate Development & IR Wahid Nawabi - Chairman, President & CEO Kevin McDonnell - SVP & CFO Conference Call Participants Peter Arment - Baird Austin Moeller - CFG Pete Skibitski - Alembic Brian Ruttenbur - Imperial Capital Operator Good evening, and thank you for standing by, and welcome to the AeroVironment Fiscal Year '23 Second Quarter Conference Cal ...

AeroVironment, Inc. (NASDAQ:AVAV) Q1 2023 Earnings Conference Call September 7, 2022 4:30 PM ET Company Participants Jonah Teeter-Balin – Senior Director-Corporate Development and Investor Relations Wahid Nawabi – Chairman, President and Chief Executive Officer Kevin McDonnell – Senior Vice President and Chief Financial Officer Conference Call Participants Ken Herbert – RBC Peter Arment – Baird Austin Moeller – Canaccord Genuity Louie DiPalma – William Blair Brian Ruttenbur – Imperial Capital Operator Ladie ...

Revenue and Sales Performance - Revenue for the three months ended July 30, 2022, was $108.5 million, an increase of $7.5 million or 7% compared to $101.0 million for the same period in 2021[171]. - Small Unmanned Aircraft Systems (Small UAS) segment generated revenue of $43.3 million, while Tactical Missile Systems (TMS) segment generated $23.0 million for the three months ended July 30, 2022[169]. - Cost of sales for the three months ended July 30, 2022, was $74.8 million, representing an increase of $2.5 million or 3% from $72.3 million in the prior year[172]. Profitability and Margins - Gross margin for the three months ended July 30, 2022, was $33.7 million, compared to $28.7 million for the same period in 2021, reflecting an increase of $5 million[168]. - Gross margin for the three months ended July 30, 2022, was $33.7 million, an increase of $5.0 million or 17% from $28.7 million for the same period in 2021, with gross margin percentage rising from 28% to 31%[173]. - The loss from operations for the three months ended July 30, 2022, was $(3.3) million, an improvement from a loss of $(12.1) million in the same period of 2021[168]. - Net loss for the three months ended July 30, 2022, was $(8.4) million, a decrease from a net loss of $(13.9) million in the same period of 2021[168]. Expenses - Research and development expenses for the three months ended July 30, 2022, were $15.0 million, compared to $13.7 million for the same period in 2021, indicating an increase of $1.3 million[168]. - SG&A expense decreased to $21.9 million, or 20% of revenue, compared to $27.1 million, or 27% of revenue, for the same period in 2021, primarily due to a reduction in acquisition-related expenses[174]. - R&D expense increased to $15.0 million, maintaining 14% of revenue, up from $13.7 million for the same period in 2021, driven by enhanced product capabilities and new product line development[177]. Cash Flow and Financial Position - Net cash provided by operating activities increased by $31.2 million to $15.9 million for the three months ended July 30, 2022, compared to a net cash used of $15.3 million for the same period in 2021[194]. - Net cash provided by investing activities was $3.8 million for the three months ended July 30, 2022, a significant increase from net cash used of $36.3 million for the same period in 2021, primarily due to the prior year's acquisition of Telerob[195]. - The company anticipates that existing cash, cash equivalents, and cash flows from operations will be sufficient to meet anticipated working capital and capital expenditure requirements for the next twelve months[186]. Backlog and Future Expectations - Funded backlog as of July 30, 2022, was approximately $203.9 million, with an additional unfunded backlog of $327.9 million, including a $235.2 million contract pending export license approval[180][181]. - The company expects continued growth in product revenue driven by small UAS and UGV product lines, alongside increased service revenue from customer-funded research and development efforts[171]. Tax and Interest Rates - The effective income tax rate was (49.3)% for the three months ended July 30, 2022, compared to 7.0% for the same period in 2021, primarily due to projected negative pre-tax income and federal R&D tax credits[178]. - The current outstanding balance of the Credit Facilities is $187.5 million, which bears a variable interest rate, and an increase in market interest rates would lead to higher interest expenses[198]. Acquisitions - The company acquired certain assets of Planck Aerosystems, Inc. for $5.1 million, financed entirely from existing cash on hand[192].

AeroVironment, Inc. (NASDAQ:AVAV) Q4 2022 Earnings Conference Call June 28, 2022 4:30 PM ET Company Participants Jonah Teeter-Balin - Senior Director of Corporate Development & IR Wahid Nawabi - President & CEO Kevin McDonnell - SVP & CFO Conference Call Participants Austin Moeller - Canaccord Genuity Ken Herbert - RBC Capital Markets Louie DiPalma - William Blair Pete Skibitski - Alembic Global Advisors Brian Ruttenbur - Imperial Capital Operator Ladies and gentlemen, thank you for standing by. And welc ...